Baseline NT‐proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation

BACKGROUND: Up to 30% of patients undergoing transcatheter aortic valve implantation (TAVI) experience minimal symptomatic benefit or die within 1 year, indicating an urgent need for enhanced patient selection. Previous analyses of baseline NT‐proBNP (N‐terminal pro‐brain natriuretic peptide) and TA...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Am Heart Assoc
Prif Awduron: Allen, Christopher J., Joseph, Jubin, Patterson, Tiffany, Hammond‐Haley, Matthew, McConkey, Hannah Z. R., Prendergast, Bernard D., Marber, Michael, Redwood, Simon R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7763793/
https://ncbi.nlm.nih.gov/pubmed/33241754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017574
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg